ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-OR056

Renal Medullary Interstitial Cell COX-2 Protects against Salt-Sensitive Hypertension and Papillary Necrosis

Session Information

Category: Hypertension

  • 1101 Hypertension: Basic and Experimental - Neural and Inflammatory Mechanisms

Authors

  • Zhang, Ming-Zhi, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Niu, Aolei, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Wang, Yinqiu, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Wang, Suwan, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Hao, Chuan-Ming, Vanderbilt University Medical Center, Nashville, United States
  • Harris, Raymond C., Vanderbilt University Medical Center, Nashville, Tennessee, United States
Background

Cycloxygenase 2 (COX-2)-derived prostaglandins regulate renal hemodynamics and salt and water homeostasis. COX-2 is highly expressed in renal medullary interstitial cell (RMICs). COX-2 inhibition causes blood pressure elevation and papillary necrosis and COX-2 sustains RMIC survival in response to hypertonicity in vitro. However, the role or RMIC COX-2 in vivo in response to stimuli has not yet been definitively studied. We investigated the effect of COX-2 deletion in RMICs on blood pressure and papillary integrity in response to high salt intake.

Methods

We used inducible COX-2 deletion in RMICs in adult mice to avoid any potential developmental abnormalities of the inner medulla/papilla. Male COX-2f/f (WT) and Tenascin-C-CreER2;COX-2f/f (RMIC COX-2-/-) mice were fed a high salt diet, and blood pressure was monitored with tail cuff plethysmography. Mice were sacrificed at 2, 4, 9 weeks. For acute salt loading, mice were IP injected with isotonic saline equivalent to 10% of body weight, placed in metabolic cages, and 4-h urine was collected.

Results

Tamoxifen efficiently induced COX-2 deletion in inner medulla/papilla of the Tenascin-C-CreER2; COX-2f/f mice. Blood pressure was similar between RMIC COX-2-/- mice and WT mice on a normal salt diet. Although blood pressure was not altered in WT mice on a high salt diet, it increased gradually in RMIC COX-2-/- mice, peaked at 4-5 weeks (131 ± 5 vs. 121 ± 4 mmHg, P < 0.05, n = 7), and then progressively decreased to levels significantly lower than corresponding WT. After return to a normal salt diet for 3 weeks, RMIC COX-2-/- mice still had lower blood pressure (101 ± 4 vs. 116 ± 3 mmHg, P < 0.05, n = 4) and a urine concentrating defect (2535 ± 97 vs. 3080 ± 120 mOsm/kg H2O of WT, P < 0.01, n = 6), in association with striking loss of papillae. Increased apoptotic cells in papillae of high salt treated RMIC COX-2-/- mice were seen 2 weeks after high salt intake. In addition, RMIC COX-2-/- mice had impaired pressure natriuresis one week after high salt diet (% of sodium excretion: 69.6 ± 8.9 vs. 98.4 ± 4.7 of WT, P < 0.05, n = 4).

Conclusion

These studies indicate that RMIC COX-2 plays an important role in salt and water homeostasis and provides cytoprotection for papillary structures in response to chronic high salt intake.

Funding

  • NIDDK Support